BioSpace News Archive

Study showed that two metabolic enzymes in the proline metabolic pathway are potential targets to inhibit cancer cell growth, and offers new hope for effective liver cancer treatments

Funding to Support Ongoing Advancement of siFi2, Lead Candidate from Company’s First-of-its-Kind Platform for Precisely Controlling Core Cell Migration Mechanisms

Signant’s TrialMax® eCOA platform and Propeller Health’s digital health platform connect to improve patient engagement and simplify data collection using real-time management and dose tracking

Researchers with Rush University Medical Center injected tumors with flu vaccines and found that this attracted immune cells to attack the tumors.

The trial is evaluating oral ibrexafungerp as a salvage treatment in difficult-to-treat mucocutaneous and invasive fungal infections that are refractory to or intolerant of current standards of care.

Synthetic biology – an engineering approach to biological science– is gaining traction in biotechnology worldwide.

While the research has only been conducted on mice, scientists from the university say their work is yielding positive results.

Here are some of the key areas to research when preparing for an interview. You can use the tips mentioned here to carry out interview background research.

Under the collaboration deal with Acerta, Veracyte will offer genomic information in support of Acerta’s oncology development program. Financial details were not disclosed.

Velabs Therapeutics GmbH, a biotech company focused on the rapid screening of functional therapeutic antibodies announced that it has entered into an exclusive licence agreement with alytas therapeutics GmbH, for the development and commercialization of alytas’ antibodies in the field of senescence, related degenerative processes and pathologies.